Keto (Ketoprofen)

Ketoprofen blocks the activity of both COX‑1 and COX‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin levels, the drug diminishes the inflammatory response and the transmission of pain signals at the affected site.

The appropriate dose of Keto is determined by the prescribing healthcare professional based on the individual’s condition, age, renal and hepatic function, and other medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of ketoprofen in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies the possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To request Keto, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketoprofen and ibuprofen belong to the same NSAID class but differ in potency and pharmacokinetics. Ketoprofen generally offers stronger analgesic and anti‑inflammatory effects at comparable doses, while ibuprofen may have a slightly lower risk of gastrointestinal irritation for some patients. Choice depends on clinical response and individual tolerance.

Keto should be stored at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Keto is taken orally, usually with a full glass of water. It can be taken with or without food, but taking it with meals may reduce stomach upset. Patients should swallow the tablet whole and avoid crushing or chewing unless instructed otherwise.

The most serious risks include gastrointestinal bleeding or ulcer perforation, severe renal impairment, hepatotoxicity, and rare but life‑threatening skin reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice signs of bleeding, sudden kidney problems, or severe skin changes.

Ketoprofen should be avoided in individuals with known hypersensitivity to ketoprofen or other NSAIDs, active peptic ulcer disease, severe heart failure, uncontrolled hypertension, or significant renal or hepatic impairment. It is also contraindicated in patients who are currently taking anticoagulants, other NSAIDs, or corticosteroids without close medical supervision.